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The extensive and widespread use of antimicrobials in-
creases the selection of antimicrobial resistant microor-
ganisms. Cephalosporins of the 3rd- and 4th-generation 
and (fluor)quinolones are broad-spectrum antimicrobi-
al compounds and of critical importance. In Switzer-
land, 231 kg and 335 kg of the total amount of 56’277 kg 
antimicrobials sold for farm animals in 2012 were ceph-
alosporins and fluoroquinolones, respectively (ARCH-
Vet 2012, 2013). In the last few years, the prevalence of 
Enterobacteriaceae isolates of human and animal origin 
showing resistance to higher generation cephalosporin 
and fluoroquinolones has increased (Lautenbach et al., 
2001; Sorlozano et al., 2007; Shaheen et al., 2013). In 
contrast to the β-lactam resistance mechanism in high-
er generation cephalosporin resistant Enterobacteriaceae 
that are mainly plasmid-encoded enzymes inacti vating 
the β-lactam-ring, the main mechanisms of quinolone 
resistance is the accumulation of mutations in the chro-
mosomally encoded DNA gyrase and DNA topoisomer-
ase IV genes. Besides, plasmid-mediated quinolone re-
sistance (PMQR) determinants, including e.g. target 
protection proteins of the qnr gene family, the amino-
glycoside acetyltransferase gene variant aac- (6’) -Ib-cr 
(for ciprofloxacin resistance) and the efflux pump gene 
qepA, contribute to a reduced susceptibility phenotype 
(Strahilevitz et al., 2009).
Since it has been previously stated (Strahilevitz et al., 
2009) that there is a link between the occurrence of 
PMQR genes and those encoding ESBLs, the purpose 
of this study was to identify and characterize the 
quinolone resistance mechanisms among extended-spec-
trum beta-lactamase (ESBL)- producing Escherichia coli 
isolated from healthy farm animals in Switzerland. 
Isolates, antimicrobial susceptibility 
testing and characterization of the  
quinolone resistance mechanisms
A collection of 90 extended-spectrum β-lactamase pro-
ducing Escherichia coli isolates from healthy farm ani-
mals (9 pig fecal samples, 17 cattle fecal samples, 5 sheep 
fecal samples and 59 chicken fecal samples from crates 
of different flocks) in Switzerland (Geser et al., 2012) 
was screened for reduced susceptibility to quinolones 
by the disc diffusion assay according the Clinical and 
Laboratory Standards Institute (CLSI) (CLSI, 2011). 
For isolates with increased level of resistance to quinolo-
nes, minimal inhibitory concentrations (MICs) of nali-
dixic acid (NA) and ciprofloxacin (CIP) were determined 
using Etest strips (bioMérieux, Marcy l’Etoile, France) 
and the criteria according to the CLSI (CLSI, 2011). 
Moreover, amplification of the quinolone resistance-de-
termining regions (QRDRs) of the gyrA, gyrB, parC and 
parE genes and PCR based detection of the plasmid- 
mediated quinolone resistance (PMQR) markers (qnrA, 
qnrB, qnrC, qnrD, qnrS, aac(6’) -Ib-cr and qepA) was per-
formed as described elsewhere (Shaheen et al., 2013). 
Custom-sequencing was performed by Microsynth 
(Balg ach, Switzerland) and the nucleotide and trans lated 
protein sequences were analyzed with CLC Main Work-
bench 6.6.1. 
Co-transferability of PMQR markers and blaESBL was 
tested by conjugation experiments which were per-
formed with plasmid-free recipient strain E. coli HK225 
strain (Strepr, Rif r) (Kayser and Morenzoni, 1982). Brief-
ly, single colonies of the donor and recipient were inoc-
ulated in LB broth (Difco Laboratories) and grown 
overnight at 37 °C. Subsequently, equal volumes of the 
donor and recipient cultures were mixed and incubated 
overnight at 37 °C without shaking. Serial dilutions were 
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then plated on LB agar (Difco Laboratories) selection 
plates supplemented with a combination of 600 μg/ml 
streptomycin (Sigma-Aldrich, Switzerland), 100 μg/ml 
rifampicin (Sigma-Aldrich, Switzerland) and 10 μg/ml 
cefotaxime (Sigma-Aldrich, Switzerland). PCR was per-
formed to identify the resistance genes acquired by the 
transconjugants. 
Results and Discussion
A total of 25 of 90 extended-spectrum β-lactamase-pro-
ducing Escherichia coli strains isolated from fecal samples 
of farm animals during a previous study (Geser et al., 
2012) showed increased levels of nalidixic acid (NA) 
resistance according to CLSI criteria (CLSI, 2011). Based 
on the Etest MIC values, twelve isolates were classified 
as resistant to NA, four were resistant to NA and showed 
intermediate resistance to CIP and nine isolates were 
resistant to both tested (fluoro)quinolones (Tab. 1). The 
findings of this study correlate well with the data of 
ESBL/AmpC-producing Enterobacteriaceae with reduced 
susceptibility to (fluoro)quinolones published in the 
ARCH-Vet 2012 report (ARCH-Vet 2012, 2013) with the 
exception of ciprofloxacin resistant isolates from chick-
en samples which have not been found in this study. 
The target gene mutations of the 25 isolates were not 
uniformly distributed among the animal species, but 
corresponded to those detected in quinolone resistant 
E. coli in a study performed in Ireland on farm animal 
isolates (Karczmarczyk et al., 2011). In our strain col-
lection, isolates from chicken origin (chicken crates) all 
showed only a single mutation in gyrA leading to the 
amino acid (aa) substitution Ser83→Leu. In contrast, all 
isolates from cattle harboured two mutations in gyrA 
(aa substitutions: Ser83→Leu, Asp87→Asn) and all of 
them but one showed an additional mutation in parC 
(aa substitution: Ser80→Ile). Four cattle isolates showed 
an additional mutation in parE (aa substitution: 
Ser458→Ala). Vogt and colleagues (Vogt et al., 2014) 
isolated recently ciprofloxacin resistant ESBL-producing 
Table 1: Detection of target gene mutations, prevalence of PMQR and MIC values of ciprofloxacin and nalidixic acid for isolates described  
in this study
Target gene mutations MIC values 
[µg/ml]a
Isolate Origin GyrA ParC ParE PMQR NAL CIP ESBL type Additional resistance patternb
Rd 52 cattle Ser83→Leu Asp87→Asn Ser80→Ile Ser458→Ala aac-6’-Ib-cr >256 >32 CTX-M-15 AM, CF, CTX, GM, TE, SXT
Rd 53 cattle Ser83→Leu Asp87→Asn Ser80→Ile Ser458→Ala aac-6’-Ib-cr >256 >32 CTX-M-15 AM, CF, CTX
Rd 142 cattle Ser83→Leu Asp87→Asn Ser80→Ile Ser458→Ala aac-6’-Ib-cr >256 >32 CTX-M-117 AM, CF, CTX, GM, TE, S, C, SXT
Rd 124 cattle Ser83→Leu Asp87→Asn Ser80→Ile Ser458→Ala >256 32 CTX-M-15 AM, CF, CTX, S
Rd 115 cattle Ser83→Leu Asp87→Asn Ser80→Ile >256 24 CTX-M-14 AM, CF, CTX, C, SXT
Rd 116 cattle Ser83→Leu Asp87→Asn Ser80→Ile >256 16 CTX-M-14 AM, CF, CTX, GM, TE, S, C, SXT
Rd 136 cattle Ser83→Leu Asp87→Asn >256 3 CTX-M-1 AM, CF, CTX, TE
Sf 108 sheep Ser83→Leu Asp87→Asn Ser80→Ile Ser458→Ala aac-6’-Ib-cr >256 >32 CTX-M-15 AM, CF, CTX, GM, TE, S, SXT
Sf 100 sheep Ser83→Leu Asp87→Asn Ser80→Ile >256 12 CTX-M-14 AM, CF, CTX, GM, TE, S, C
Sf 102 sheep Ser83→Leu Asp87→Asn Ser80→Ile >256 12 CTX-M-14 AM, CF, CTX, GM, TE, S, C
Sf 2 sheep Ser83→Leu >256 0.38 CTX-M-1 AM, CF, CTX, TE, S, C
Sw 17 pig Ser83→Leu Asp87→Asn Ser80→Ile >256 3 CTX-M-1 AM, CF, CTX, TE, S
Sw18 pig Ser83→Leu Asp87→Asn Ser80→Ile >256 3 CTX-M-1 AM, CF, CTX, S, C
Sw 16 pig Ser83→Leu Asp87→Asn Ser80→Ile >256 3 CTX-M-1 AM, CF, CTX, GM, TE, S, SXT
Sw 65 pig Ser83→Leu >256 0.19 CTX-M-1 AM, CF, CTX, TE
Sw 14 pig Ser83→Leu >256 0.125 CTX-M-1 AM, CF, CTX, TE
Sw 13 pig Ser83→Leu >256 0.094 CTX-M-1 AM, CF, CTX, TE, S, SXT
H 77 chicken Ser83→Leu >256 0.25 SHV-12 AM, CF, CTX, TE, SXT
H 88 chicken Ser83→Leu >256 0.25 CTX-M-1 AM, CF, CTX, SXT
H 17 chicken Ser83→Leu >256 0.125 CTX-M-1 AM, CF, CTX, TE
H 35 chicken Ser83→Leu 256 0.25 CTX-M-1 AM, CF, CTX, TE, SXT
H 34 chicken Ser83→Leu 256 0.125 SHV-12 AM, CF, TE, SXT
H 23 chicken Ser83→Leu 256 0.19 TEM-52 AM, CF, CTX
H 2 chicken Ser83→Leu 256 0.094 SHV-12 AM, CF, CTX, TE, C
H 84 chicken Ser83→Leu 96 0.19 CTX-M-1 AM, CF, CTX, TE, SXT
HK225c – – 4 0.023 – S, Rif
a NAL, nalidixic acid; CIP, ciprofloxacin.
b AM, ampicillin; C, chloramphenicol; CF, cephalothin; CTX, cefotaxime; GM, gentamicin; TE, tetracycline; S, streptomycin; SXT, trimethoprim-
sulfa methoxazole.
c E. coli recipient strain used for conjugation experiments. 
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genes (Poirel et al., 2012a). So far, the modified acetyl-
transferase was frequently detected in E. coli isolates 
harboring blaCTX-M-15 from companion animal (Gibson 
et al., 2010; Shaheen et al., 2013), and in human E. coli 
isolates (Poirel et al., 2012b; Strahilevitz et al., 2009). 
In summary, the presence of E. coli co-expressing 
(fluoro)quinolone resistance along with extended-spec-
trum β-lactamases in healthy livestock is worrisome, as 
they might spread into the farm environment and along 
the food chain. Although these strains belong the com-
mon gut microflora and are usually unproblematic for 
their carrier, their occurrence is an important veterinary 
public health issue. Isolates characterized during this 
study exhibit resistance mechanisms to the two most 
frequent used antimicrobial classes in human medicine. 
Besides harbouring PMQR determinants and blaESBL 
genes, these bacterial isolates exhibit resistances to oth-
er antimicrobial classes such as for example sulfona-
mides and tetracyclines. These multi-drug resistant 
bacteria are an important reservoir for antimicrobial 
resistance genes, from where the resistance determinants 
might be mobilized by plasmids, transposon or other 
mobile genetic elements and integrated into pathogenic 
(zoonotic) species.
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E. coli from Swiss chicken meat harbouring the same aa 
substitution in GyrA (Ser83→Leu, Asp87→Asn) but a 
different substitution in ParC (Ser80→Arg). The isolates 
from sheep and swine showed mainly two substitutions 
in GyrA (Ser83→Leu and Asp87→Asn) and one in ParC 
(Ser80→Ile). No mutations were found in gyrB in any 
isolates. A single mutation in the QRDR of gyrA is suf-
ficient to generate a high-level quinolone, and a double 
mutation even a high-level fluoroquinolone resistance 
phenotype (Vila et al., 1994). 
Plasmid-mediated quinolone resistance (PMQR) deter-
minants were so far rarely found in isolates from food 
producing animals (Kirchner et al., 2011; Liu et al., 
2011). The qnrA, qnrB, qnrC, qnrD, qnrS and qepA genes 
were not detected in this study. However, we describe 
one E. coli isolate from a sheep (Sf 108) and three isolates 
from cattle (Rd52, Rd53 and Rd142.11), which harbor 
the ciprofloxacin-resistance variant of the aminoglyco-
side acetyltransferase, AAC(6’)-Ib-cr. The contribution 
of PMQR determinants to the fluoroquinolone resist-
ance phenotype is low, thus the transconjugation exper-
iments were performed by the selection for blaESBL, since 
it has been shown that acc(6’) -Ib-cr is often located on 
the same plasmid as the ESBL genes (Strahilevitz et al., 
2009). Transconjugation was possible for two (Rd52 and 
Sf108) of the four isolates by selection for the co-trans-
ferred blaCTX-M-15 gene. Although the contribution of 
AAC(6’)-Ib-cr to the resistance level to certain fluoro-
quinolones (e.g. ciprofloxacin and norfloxacin) is low, 
it is proposed that it may promote the accumulation of 
mutations in DNA gyrase and DNA topoisomerase IV 
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